Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists

Author： Singh V. Sud K. Mittal B.R. Kohli H.S. Gupta K.L. Sakhuja V.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.34, Iss.8, 2002-12, pp. : 3191-3192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene

By Torregrosa J.V. Poch E. Oriola J. Campistol J.M. Cofan F. Inigo P. Oppenheimer F.

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2319-2320

Elsevier

Access to resources Recommend Favorite

Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis

By Hortal L. Fernandez A. Vega N. Rodrguez J.C. Losada A. Lorenzo M. Plaza C. Palop L.

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis

By Tsang W.K. Tong K.L. Chan H.W.H.

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3072-3073

Elsevier

Access to resources Recommend Favorite

Postrenal Transplant Health Beliefs and Ethnicity

By Compliance Study Group Greenstein S.M. Siegal B.

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3741-3742

Elsevier

Access to resources Recommend Favorite

Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis

By Inigo P. Torregrosa J.V. Campistol J.M. Oppenheimer F.

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2321-2321

Elsevier

Access to resources Recommend Favorite